What’s Going On With Equinor Shares Monday?
Equinor ASA shares are down amid reports of delayed restart of Hammerfest LNG plant due to gas leak.
Double Good News For AstraZeneca’s Breast Cancer Drugs
Results from AstraZeneca's Enhertu trial vs. chemotherapy in HR-positive, HER2-low metastatic breast cancer.
TotalEnergies To Fast-Track Iraq Solar Power and Gas Projects: Report
TotalEnergies reportedly plans to finish solar project and gas project in Iraq in 2025, to produce 50 mcf/d in Iraq's gas project. TotalEnergies aims to boost energy production.
Turkey Reportedly Turns East For Gas, Reportedly Eyes Exxon Deal To Ditch Russia
Exxon Mobil is reportedly in talks with Turkey for LNG deal to reduce dependence on Russia. Potential for 2.5M tonnes annually, costing $1.1B. XOM ahead of schedule to double LNG portfolio by 2030.
Last Week’s Worst-Performing Stocks: Are These 10 Large-Cap Stocks In Your Portfolio? (April 21-27, 2024)
10 worst performing large-cap stocks last week: LKQ, MSCI, TXT, EDU, BMY, MANH, RS, META, LUV, NUE. Analysts cut price targets for many.
Tracking Last Week’s Top Performers: Are These 15 Large-Cap Stocks In Your Portfolio? (April 21-27)
Last week's top performers included Vertiv Holdings, Tesla, Tyler Technologies, and Newmont Corporation.
Let’s Spill The Tea: Top Consumer Tech News From Last Week That You Should Know (April 21-27)
U.S. House of Representatives passes bill that could lead to TikTok ban, Microsoft launched Phi-3 Mini, and more.
Auto Watchdog Intensifies Probe Into Tesla’s Autopilot Recall As Safety Concerns Mount
NHTSA investigating Tesla's handling of recall affecting 2M vehicles with Autopilot software. Concerns over safety, data gaps, and misleading marketing.
Strong Quarterly Earnings Fuel Market Optimism Despite Inflation Concerns, Slowing Economic Growth: This Week In The Market
Tech stocks, as tracked by the Invesco QQQ Trust, experienced their best week in 2024. Energy stocks, this year's best performers, faltered.
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfizer, BioNTech, and CureVac, as GSK joins the fray, alleging patent infringement in mRNA technology.